Biography • Life Sciences - Regulatory

Paul Kalb, who heads Sidley's national healthcare practice and serves as a global coordinator of its life sciences practice, brings an uncommon clinical perspective, grounded in his experience as an attending physician at the Memorial Sloan-Kettering Cancer Center, to bear in his work for a wide range of healthcare clients. He has successfully represented many of the world's leading drug, biotech and device manufacturers and hospitals in criminal, civil, and administrative enforcement actions involving healthcare fraud and abuse and off-label promotion. He has led teams that defended numerous matters and negotiated ground-breaking settlement agreements and corporate integrity agreements.

Representative matters that are public include representation of GlaxoSmithKline in corporate integrity agreement negotiation; representation of Genentech Inc in connection with a lengthy criminal and civil investigation regarding Rituxan; favourably resolving a case brought against client Novo Nordisk regarding allegations of illegal promotional activity; representation of GE Healthcare in connection with an investigation of the company's pricing and promotion of a radiopharmaceutical product; and defending Eli Lilly and Company in two investigations by federal and state prosecutors.

Paul is an author, along with Robert Fabrikant, Mark Hopson and Pamela Bucy, of Health Care Fraud: Enforcement and Compliance and has written numerous articles in legal, medical, and industry publications.

Paul is a graduate of Yale Law School, where he was an editor of the Yale Law Journal. Prior to attending law school, he received his MD degree, magna cum laude, from the Boston University School of Medicine and completed his residency in internal medicine at the New York Hospital-Cornell Medical Center.